Showing 61 - 80 results of 3,563 for search '"Pfizer"', query time: 0.13s Refine Results
  1. 61

    A Survey of the Side Effects of Pfizer/BioNTech COVID-19 Vaccine among Vaccinated Adults in Iraq by Abubakir Saleh, Nazar P. Shabila

    Published 2023-12-01
    “… Background: Pfizer-BioNTech vaccine was one of the first vaccines developed for COVID-19 to be used in Iraq. …”
    Get full text
    Article
  2. 62

    Reacciones cutáneas a la vacuna Pfizer-BioNTech contra COVID-19. Una experiencia ecuatoriana by Iván Chérrez-Ojeda, Karla Robles-Velasco, María F. Osorio, Daniel Mejía-Leiva, Annia Chérrez, Sofía Chérrez, Jonathan A. Bernstein, Zouina Sarfraz, Miguel Félix

    Published 2022-06-01
    “… Objetivo: Evaluar las reacciones cutáneas tras la administración de la vacuna COVID-19 de Pfizer-BioNTech. Métodos: Se realizó un estudio observacional transversal en trabajadores de la salud, pertenecientes a la ciudad de Guayaquil-Ecuador, de marzo a mayo de 2021. …”
    Get full text
    Article
  3. 63

    Some Aspects of Online Discourse Manipulation on Social Media (the case of Instagram English Presentational Discourse of Pfizer Inc.) by Lilia I. Trius, Nataliya V. Papka

    Published 2022-03-01
    “…The English-language texts of Pfizer’s publications on the company’s official pages on the social network Instagram were taken as material for the analysis. …”
    Get full text
    Article
  4. 64

    Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices. by Burcu Kapar, Steven Buigut, Faisal Rana

    Published 2022-01-01
    “…This study explores how the US stock market reacted to the news of a successful development of vaccine by Pfizer and Biontech on November 9, 2020. In particular, the study analyses the effect of the vaccine announcement on 11 sector indices and 79 subsector indices. …”
    Get full text
    Article
  5. 65

    Advanced Liver Fibrosis Correlates With Impaired Efficacy of Pfizer‐BioNTech COVID‐19 Vaccine in Medical Employees by Asher Shafrir, Johnny Amer, David Hakimian, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Ashraf Imam, Abed Khalaileh, Rifaat Safadi

    Published 2022-06-01
    “…The Pfizer‐BioNTech coronavirus disease 2019 (COVID‐19) vaccine has been offered to nonallergic ≥16‐year‐old Israeli adults since December 19, 2020. …”
    Get full text
    Article
  6. 66

    Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech by Dulat Bekbolsynov, Andrew Waack, Camryn Buskey, Shalmali Bhadkamkar, Keegan Rengel, Winnifer Petersen, Mary Lee Brown, Tanaya Sparkle, Dinkar Kaw, Fayeq Jeelani Syed, Saurabh Chattopadhyay, Ritu Chakravarti, Sadik Khuder, Beata Mierzejewska, Michael Rees, Stanislaw Stepkowski

    Published 2024-01-01
    “…We propose that the higher number of non-responders in the Pfizer-BioNTech group than the Moderna group was caused by a more potent activity of regulatory Tr1 cells in KT recipients vaccinated with the Pfizer-BioNTech vaccine.…”
    Get full text
    Article
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74

    Adverse events of the Pfizer-BioNTech COVID-19 vaccine in Korean children and adolescents aged 5 to 17 years by Seontae Kim, Yeseul Heo, Soon-Young Seo, Do Sang Lim, Enhi Cho, Yeon-Kyeng Lee

    Published 2022-10-01
    “…Objectives This study aimed to identify potential safety signals and adverse events following the primary Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccination series among children and adolescents aged 5 to 17 years in the Republic of Korea. …”
    Get full text
    Article
  15. 75
  16. 76

    Anaphylatoxin Complement 5a in Pfizer BNT162b2-Induced Immediate-Type Vaccine Hypersensitivity Reactions by Xin Rong Lim, Grace Yin Lai Chan, Justina Wei Lynn Tan, Carol Yee Leng Ng, Choon Guan Chua, Guat Bee Tan, Stephrene Seok Wei Chan, Kiat Hoe Ong, Ying Zhi Tan, Sarah Hui Zhen Tan, Claire Min Li Teo, Samuel Shang Ming Lee, Bernard Yu Hor Thong, Bernard Pui Lam Leung

    Published 2023-05-01
    “…We investigate the mechanisms of immediate-type hypersensitivity reactions to the Pfizer BNT162b2 vaccine and the response of antibodies to the polyethylene glycol (PEG)ylated lipid nanoparticle after two doses of vaccination. …”
    Get full text
    Article
  17. 77
  18. 78
  19. 79

    Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech) by Rumiko Shimazawa, Masayuki Ikeda

    Published 2021-12-01
    “…Although no regulatory authority has recognized ICH as an adverse event associated with tozinameran (BNT162b2, Pfizer-BioNTech), fatal and non-fatal cases have been reported. …”
    Get full text
    Article
  20. 80